A
Adaptive Biotechnologies Corporation
Q3 2025 earnings expected
Quarter
Jul – Sep
Expected
November 14, 2025(ET)
Revenue
This quarter$94M
Analyst estimate$65M▲ +45.4%
Year ago (Sep '24)$46M▲ +102.4%
EPS
This quarter-$0.15
Analyst estimate-$0.15▼ -2.3%
Year ago (Sep '24)-$0.22▲ +31.8%
Revenue Growth Trajectory
+35%YoY
Last 6 quarters · 5 analysts